Glenmark Pharmaceuticals has submitted a copy of press release dated October 23, 2015 titled ‘Glenmark announces Strategic Development & Licensing Agreement with Celon, Poland for generic Seretide Accuhaler in Europe’
The above information is a part of company’s filings submitted to BSE.